Posted Mar. 28, 2012 at 11:13 a.m.

Premium Lock Charlotte firm's Parkinson's drug could win FDA approval

Published: 2012-03-28 11:13:40
Updated: 2012-03-28 11:13:40

Chelsea Chelsea

Chelsea Therapeutics' Northera passed a hurdle last month when an independent advisory panel to the U.S. Food and Drug Administration voted 7-4 to recommend FDA approval. The recommendation is not binding but it is considered when the FDA deliberates whether to approve a new drug....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll